Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00383396 · ClinicalTrials.gov registry record · Phase 4

Efficacy of Topical Cyclosporine 0.05% in the Prevention of Ocular Surface Inflammation Secondary to Pterygia

A Phase 4 study, sponsored by Innovative Medical.

Completed
Registry status
Phase 4
Development phase

NCT00383396: Completed Phase 4 study, sponsored by Innovative Medical.

NCT00383396 is a Phase 4 study that has completed, run by Innovative Medical. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00383396, a Phase 4 study, has completed, sponsored by Innovative Medical.

COMPLETED
Registry status
Phase 4
Development phase

Study Summary

To Determine if topical cyclosporine 0.05% BID prevents recurrent inflammation and improves comfort in eyes with pterygia.

Interventions

  • DRUG Topical Cyclosporine

Trial Details

FieldValue
Phase Phase 4
Innovative Medical

44 total trials

What the finished NCT00383396 record still lists

NCT00383396 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.

The record links to 0 conditions, and to 1 intervention - of which Topical Cyclosporine is the first listed.

NCT00383396 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00383396 about?

NCT00383396 is a clinical study titled "Efficacy of Topical Cyclosporine 0.05% in the Prevention of Ocular Surface Inflammation Secondary to Pterygia". To Determine if topical cyclosporine 0.05% BID prevents recurrent inflammation and improves comfort in eyes with pterygia.

What is the current status of trial NCT00383396?

This trial is currently completed. It is a Phase 4 study.

What interventions are being tested in trial NCT00383396?

The interventions under investigation include: Topical Cyclosporine (DRUG).

Who is sponsoring clinical trial NCT00383396?

This trial is sponsored by Innovative Medical, which has 44 total clinical trials registered on ClinicalTrials.gov.

Source: ClinicalTrials.gov NCT00383396, the US trial registry maintained by the National Library of Medicine. NCT00383396 (unsized enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.